Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.48 is 78% below its 5-year average of 15.98, near the low end of its 5-year range (3.48–96.85).
As of the fiscal period ended Tuesday, June 30, 2026. 39.09% below its 12-month average of 5.71.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.48.
CURRENT RATIO
3.48
CURRENT RATIO AVG TTM
5.71
CURRENT RATIO AVG 3Y
13.31
CURRENT RATIO AVG 5Y
15.98
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-39.09%
CURRENT VS 3Y AVG
-73.89%
CURRENT VS 5Y AVG
-78.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-7.33%
vs the sector median at left
ARS Pharmaceuticals, Inc.
Market Cap
$426.13M
Current Ratio
3.48
TTM Avg
5.71
3Y Avg
13.31
5Y Avg
15.98
Market Cap
$424.75M
Current Ratio
25.05
TTM Avg
8.87
3Y Avg
10.83
5Y Avg
12.06
Market Cap
$419.61M
Current Ratio
6.74
TTM Avg
3.59
3Y Avg
4.96
5Y Avg
4.92
Market Cap
$437.20M
Current Ratio
22.29
TTM Avg
19.64
3Y Avg
11.19
5Y Avg
11.30
Market Cap
$413.62M
Current Ratio
9.89
TTM Avg
6.34
3Y Avg
6.34
5Y Avg
6.34
Market Cap
$412.48M
Current Ratio
16.52
TTM Avg
13.61
3Y Avg
8.86
5Y Avg
8.86
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | $426.13M | 3.48 | 5.71 | 13.31 | 15.98 |
| Tilray Brands, Inc. (TLRY)vs › | $426.64M | 2.21 | 2.33 | 2.18 | 2.30 |
| NeoGenomics, Inc. (NEO)vs › | $425.21M | 3.60 | 3.12 | 4.79 | 5.52 |
| Prothena Corporation plc (PRTA)vs › | $424.75M | 25.05 | 8.87 | 10.83 | 12.06 |
| Editas Medicine, Inc. (EDIT)vs › | $429.69M | 3.19 | 3.65 | 4.66 | 6.11 |
| Senseonics Holdings, Inc. (SENS)vs › | $419.61M | 6.74 | 3.59 | 4.96 | 4.92 |
| Tectonic Therapeutic, Inc. (TECX)vs › | $437.20M | 22.29 | 19.64 | 11.19 | 11.30 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $413.62M | 9.89 | 6.34 | 6.34 | 6.34 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $412.48M | 16.52 | 13.61 | 8.86 | 8.86 |
| Assembly Biosciences, Inc. (ASMB)vs › | $439.84M | 13.99 | 3.82 | 4.25 | 5.96 |
Current Ratio
3.48
Quick Ratio
3.28
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.48 |
| 2026-03-31 | 4.94 |
| 2025-12-31 | 7.28 |
| 2025-09-30 | 6.66 |
| 2025-06-30 | 6.17 |
| 2025-03-31 | 11.00 |
| 2024-12-31 | 14.26 |
| 2024-09-30 | 12.56 |
| 2024-06-30 | 32.82 |
| 2024-03-31 | 60.90 |
| 2023-12-31 | 96.85 |
| 2023-09-30 | 21.87 |
| 2023-06-30 | 25.37 |
| 2023-03-31 | 27.18 |
| 2022-12-31 | 51.01 |
| 2022-09-30 | 4.69 |
| 2022-06-30 | 6.08 |
| 2022-03-31 | 17.65 |
| 2021-12-31 | 7.42 |
| 2021-09-30 | 19.90 |
| 2021-06-30 | 23.35 |
| 2021-03-31 | 32.63 |
| 2020-12-31 | 40.69 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.59 |
